124 related articles for article (PubMed ID: 31800235)
1. Antigen Delivery to Antigen-Presenting Cells for Adaptive Immune Response by Self-Assembled Anionic Polysaccharide Nanogel Vaccines.
Miura R; Sawada SI; Mukai SA; Sasaki Y; Akiyoshi K
Biomacromolecules; 2020 Feb; 21(2):621-629. PubMed ID: 31800235
[TBL] [Abstract][Full Text] [Related]
2. Structural effects and lymphocyte activation properties of self-assembled polysaccharide nanogels for effective antigen delivery.
Miura R; Tahara Y; Sawada SI; Sasaki Y; Akiyoshi K
Sci Rep; 2018 Nov; 8(1):16464. PubMed ID: 30405172
[TBL] [Abstract][Full Text] [Related]
3. PEGylated cationic liposomes robustly augment vaccine-induced immune responses: Role of lymphatic trafficking and biodistribution.
Zhuang Y; Ma Y; Wang C; Hai L; Yan C; Zhang Y; Liu F; Cai L
J Control Release; 2012 Apr; 159(1):135-42. PubMed ID: 22226776
[TBL] [Abstract][Full Text] [Related]
4. Self-assembled polysaccharide nanogel delivery system for overcoming tumor immune resistance.
Muraoka D; Harada N; Shiku H; Akiyoshi K
J Control Release; 2022 Jul; 347():175-182. PubMed ID: 35526613
[TBL] [Abstract][Full Text] [Related]
5. Bioreducible alginate-poly(ethylenimine) nanogels as an antigen-delivery system robustly enhance vaccine-elicited humoral and cellular immune responses.
Li P; Luo Z; Liu P; Gao N; Zhang Y; Pan H; Liu L; Wang C; Cai L; Ma Y
J Control Release; 2013 Jun; 168(3):271-9. PubMed ID: 23562637
[TBL] [Abstract][Full Text] [Related]
6. Nanogel-Mediated antigen delivery: Biocompatibility, immunogenicity, and potential for tailored vaccine design across species.
Laura Soriano Pérez M; Montironi I; Alejandro Funes J; Margineda C; Campra N; Noelia Cariddi L; José Garrido J; Molina M; Alustiza F
Vaccine; 2024 Jun; 42(17):3721-3732. PubMed ID: 38719694
[TBL] [Abstract][Full Text] [Related]
7. Rational Design of PLGA Nanoparticle Vaccine Delivery Systems To Improve Immune Responses.
Gu P; Wusiman A; Zhang Y; Liu Z; Bo R; Hu Y; Liu J; Wang D
Mol Pharm; 2019 Dec; 16(12):5000-5012. PubMed ID: 31621331
[TBL] [Abstract][Full Text] [Related]
8. Targeting Suppressive Oligonucleotide to Lymph Nodes Inhibits Toll-like Receptor-9-Mediated Activation of Adaptive Immunity.
Yu C; An M; Jones E; Liu H
Pharm Res; 2018 Feb; 35(3):56. PubMed ID: 29423660
[TBL] [Abstract][Full Text] [Related]
9. Lymph Node-Targeting Nanovaccine through Antigen-CpG Self-Assembly Potentiates Cytotoxic T Cell Activation.
Xi X; Zhang L; Lu G; Gao X; Wei W; Ma G
J Immunol Res; 2018; 2018():3714960. PubMed ID: 30018987
[TBL] [Abstract][Full Text] [Related]
10. Lymphatic-targeted cationic liposomes: a robust vaccine adjuvant for promoting long-term immunological memory.
Wang C; Liu P; Zhuang Y; Li P; Jiang B; Pan H; Liu L; Cai L; Ma Y
Vaccine; 2014 Sep; 32(42):5475-83. PubMed ID: 25110295
[TBL] [Abstract][Full Text] [Related]
11. Development of effective cancer vaccine using targeting system of antigen protein to APCs.
Kurosaki T; Kitahara T; Nakamura T; Nishida K; Fumoto S; Kodama Y; Nakagawa H; Higuchi N; Sasaki H
Pharm Res; 2012 Feb; 29(2):483-9. PubMed ID: 21887598
[TBL] [Abstract][Full Text] [Related]
12. Nanogel vaccines targeting dendritic cells: contributions of the surface decoration and vaccine cargo on cell targeting and activation.
Thomann-Harwood LJ; Kaeuper P; Rossi N; Milona P; Herrmann B; McCullough KC
J Control Release; 2013 Mar; 166(2):95-105. PubMed ID: 23220107
[TBL] [Abstract][Full Text] [Related]
13. Immune responses to vaccines delivered by encapsulation into and/or adsorption onto cationic lipid-PLGA hybrid nanoparticles.
Liu L; Ma P; Wang H; Zhang C; Sun H; Wang C; Song C; Leng X; Kong D; Ma G
J Control Release; 2016 Mar; 225():230-9. PubMed ID: 26826307
[TBL] [Abstract][Full Text] [Related]
14. Effects of gold nanoparticle-based vaccine size on lymph node delivery and cytotoxic T-lymphocyte responses.
Kang S; Ahn S; Lee J; Kim JY; Choi M; Gujrati V; Kim H; Kim J; Shin EC; Jon S
J Control Release; 2017 Jun; 256():56-67. PubMed ID: 28428066
[TBL] [Abstract][Full Text] [Related]
15. Development of a nanogel-based nasal vaccine as a novel antigen delivery system.
Nakahashi-Ouchida R; Yuki Y; Kiyono H
Expert Rev Vaccines; 2017 Dec; 16(12):1231-1240. PubMed ID: 29053938
[TBL] [Abstract][Full Text] [Related]
16. Granulocyte/macrophage-colony stimulating factor produced by recombinant avian poxviruses enriches the regional lymph nodes with antigen-presenting cells and acts as an immunoadjuvant.
Kass E; Panicali DL; Mazzara G; Schlom J; Greiner JW
Cancer Res; 2001 Jan; 61(1):206-14. PubMed ID: 11196163
[TBL] [Abstract][Full Text] [Related]
17. Cationic polypeptide micelle-based antigen delivery system: a simple and robust adjuvant to improve vaccine efficacy.
Luo Z; Li P; Deng J; Gao N; Zhang Y; Pan H; Liu L; Wang C; Cai L; Ma Y
J Control Release; 2013 Sep; 170(2):259-67. PubMed ID: 23742880
[TBL] [Abstract][Full Text] [Related]
18. Cationic polymer modified PLGA nanoparticles encapsulating Alhagi honey polysaccharides as a vaccine delivery system for ovalbumin to improve immune responses.
Wusiman A; Gu P; Liu Z; Xu S; Zhang Y; Hu Y; Liu J; Wang D; Huang X
Int J Nanomedicine; 2019; 14():3221-3234. PubMed ID: 31123399
[No Abstract] [Full Text] [Related]
19. Cascade Cytosol Delivery of Dual-Sensitive Micelle-Tailored Vaccine for Enhancing Cancer Immunotherapy.
Jiang D; Mu W; Pang X; Liu Y; Zhang N; Song Y; Garg S
ACS Appl Mater Interfaces; 2018 Nov; 10(44):37797-37811. PubMed ID: 30360105
[TBL] [Abstract][Full Text] [Related]
20. Protein antigen conjugated with cholesteryl amino-pullulan nanogel shows delayed degradation in dendritic cells and augmented immunogenicity.
Long W; Kunitake S; Sawada SI; Akiyoshi K; Tsubata T
Vaccine; 2021 Dec; 39(52):7526-7530. PubMed ID: 34852944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
